These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20099977)

  • 21. Clinical relevance of serum vascular endothelial growth factor and interleukin-6 in patients with colorectal cancer.
    Eldesoky A; Shouma A; Mosaad Y; Elhawary A
    Saudi J Gastroenterol; 2011; 17(3):170-3. PubMed ID: 21546718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
    Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
    Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between VEGF and p53 expression and tumor cell proliferation in human gastrointestinal carcinomas.
    Montero E; Abreu C; Tonino P
    J Cancer Res Clin Oncol; 2008 Feb; 134(2):193-201. PubMed ID: 17636327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating and tissue galectin-1 and galectin-3 in colorectal carcinoma: association with clinicopathological parameters, serum CEA, IL-17 and IL23.
    Petrovic S; Radosavljevic GD; Pantic J; Jovanovic I; Jankovic N; Arsenijevic N
    J BUON; 2016; 21(4):941-949. PubMed ID: 27685917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis.
    Cressey R; Wattananupong O; Lertprasertsuke N; Vinitketkumnuen U
    BMC Cancer; 2005 Oct; 5():128. PubMed ID: 16202150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract.
    Biasi F; Guina T; Maina M; Nano M; Falcone A; Aroasio E; Saracco GM; Papotti M; Leonarduzzi G; Poli G
    PLoS One; 2012; 7(7):e41839. PubMed ID: 22848630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the apoptosis repressor with caspase recruitment domain (ARC) in liver metastasis of colorectal cancer and its correlation with DNA mismatch repair proteins and p53.
    Tóth C; Meinrath J; Herpel E; Derix J; Fries J; Buettner R; Schirmacher P; Heikaus S
    J Cancer Res Clin Oncol; 2016 May; 142(5):927-35. PubMed ID: 26721253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
    Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
    Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum IL-17F combined with VEGF as potential diagnostic biomarkers for oral squamous cell carcinoma.
    Ding L; Hu EL; Xu YJ; Huang XF; Zhang DY; Li B; Hu QG; Ni YH; Hou YY
    Tumour Biol; 2015 Apr; 36(4):2523-9. PubMed ID: 25613064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.
    Akbulut H; Altuntas F; Akbulut KG; Ozturk G; Cindoruk M; Unal E; Icli F
    Cytokine; 2002 Nov; 20(4):184-90. PubMed ID: 12543084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of thrombospondin-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
    Kaio E; Tanaka S; Oka S; Hiyama T; Kitadai Y; Haruma K; Chayama K
    Int J Oncol; 2003 Oct; 23(4):901-11. PubMed ID: 12963968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
    Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of serum angiogenic activity in colorectal cancer patients.
    Gonzalez FJ; Quesada AR; Sevilla I; Baca JJ; Medina MA; Amores J; Diaz JM; Rius-Diaz F; Marques E; Alba E
    J Cell Mol Med; 2007; 11(1):120-8. PubMed ID: 17367506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
    Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.
    Nakayama Y; Sako T; Shibao K; Onitsuka K; Nagashima N; Hirata K; Nagata N; Itoh H
    Anticancer Res; 2000; 20(6A):4097-102. PubMed ID: 11131678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma.
    Kondo Y; Arii S; Furutani M; Isigami S; Mori A; Onodera H; Chiba T; Imamura M
    Cancer; 2000 Apr; 88(8):1820-7. PubMed ID: 10760758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of molecular marker expression can predict clinical outcome in colon carcinomas.
    Galizia G; Lieto E; Ferraraccio F; Orditura M; De Vita F; Castellano P; Imperatore V; Romano C; Ciardiello F; Agostini B; Pignatelli C
    Clin Cancer Res; 2004 May; 10(10):3490-9. PubMed ID: 15161706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma.
    Huang SP; Wu MS; Wang HP; Yang CS; Kuo ML; Lin JT
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1165-9. PubMed ID: 12453275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients.
    Ito H; Miki C
    Scand J Gastroenterol; 1999 Nov; 34(11):1139-43. PubMed ID: 10582766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.